ID   CC14A_HUMAN             Reviewed;         594 AA.
AC   Q9UNH5; A6MA65; B1AQ14; B1AQ15; O43171; O60727; O60728; Q52LH9;
AC   Q8IXX0;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 144.
DE   RecName: Full=Dual specificity protein phosphatase CDC14A;
DE            EC=3.1.3.16;
DE            EC=3.1.3.48;
DE   AltName: Full=CDC14 cell division cycle 14 homolog A;
GN   Name=CDC14A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9367992; DOI=10.1074/jbc.272.47.29403;
RA   Li L., Ernsting B.R., Wishart M.J., Lohse D.L., Dixon J.E.;
RT   "A family of putative tumor suppressors is structurally and
RT   functionally conserved in humans and yeast.";
RL   J. Biol. Chem. 272:29403-29406(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10409437; DOI=10.1006/geno.1999.5863;
RA   Wong A.K.C., Chen Y., Lian L., Ha P.C., Petersen K., Laity K.,
RA   Carillo A., Emerson M., Heichman K., Gupte J., Tavtigian S.V.,
RA   Teng D.H.-F.;
RT   "Genomic structure, chromosomal location, and mutation analysis of the
RT   human CDC14A gene.";
RL   Genomics 59:248-251(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Placenta;
RA   Hao L., Baskerville C., Charbonneau H.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Belyaev A.S., Kolokithas A., Monell C.R.;
RT   "Human CDC14A splice variant.";
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-345 AND PHE-589.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   DEPHOSPHORYLATION OF FZR1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   CYS-278.
RX   PubMed=11598127; DOI=10.1074/jbc.M108126200;
RA   Bembenek J., Yu H.;
RT   "Regulation of the anaphase-promoting complex by the dual specificity
RT   phosphatase human Cdc14a.";
RL   J. Biol. Chem. 276:48237-48242(2001).
RN   [10]
RP   SUBSTRATE SPECIFICITY, FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF ASP-251; CYS-278 AND ARG-284.
RX   PubMed=12134069; DOI=10.1091/mbc.01-11-0535;
RA   Kaiser B.K., Zimmerman Z.A., Charbonneau H., Jackson P.K.;
RT   "Disruption of centrosome structure, chromosome segregation, and
RT   cytokinesis by misexpression of human Cdc14A phosphatase.";
RL   Mol. Biol. Cell 13:2289-2300(2002).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF MET-362 AND
RP   ILE-364.
RX   PubMed=11901424; DOI=10.1038/ncb777;
RA   Mailand N., Lukas C., Kaiser B.K., Jackson P.K., Bartek J., Lukas J.;
RT   "Deregulated human Cdc14A phosphatase disrupts centrosome separation
RT   and chromosome segregation.";
RL   Nat. Cell Biol. 4:317-322(2002).
RN   [12]
RP   INTERACTION WITH KIF20A, AND SUBCELLULAR LOCATION.
RX   PubMed=15263015; DOI=10.1083/jcb.200403084;
RA   Gruneberg U., Neef R., Honda R., Nigg E.A., Barr F.A.;
RT   "Relocation of Aurora B from centromeres to the central spindle at the
RT   metaphase to anaphase transition requires MKlp2.";
RL   J. Cell Biol. 166:167-172(2004).
RN   [13]
RP   FUNCTION AS SIRT2 PHOSPHATASE.
RX   PubMed=17488717; DOI=10.1074/jbc.M702990200;
RA   North B.J., Verdin E.;
RT   "Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent
RT   phosphorylation.";
RL   J. Biol. Chem. 282:19546-19555(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484 AND SER-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   INVOLVEMENT IN DFNB105.
RX   PubMed=27259055; DOI=10.1016/j.ajhg.2016.04.015;
RA   Delmaghani S., Aghaie A., Bouyacoub Y., El Hachmi H., Bonnet C.,
RA   Riahi Z., Chardenoux S., Perfettini I., Hardelin J.P., Houmeida A.,
RA   Herbomel P., Petit C.;
RT   "Mutations in CDC14A, encoding a protein phosphatase involved in hair
RT   cell ciliogenesis, cause autosomal-recessive severe to profound
RT   deafness.";
RL   Am. J. Hum. Genet. 98:1266-1270(2016).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] TYR-493.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Dual-specificity phosphatase. Required for centrosome
CC       separation and productive cytokinesis during cell division.
CC       Dephosphorylates SIRT2 around early anaphase. May dephosphorylate
CC       the APC subunit FZR1/CDH1, thereby promoting APC-FZR1 dependent
CC       degradation of mitotic cyclins and subsequent exit from mitosis.
CC       {ECO:0000269|PubMed:11901424, ECO:0000269|PubMed:12134069,
CC       ECO:0000269|PubMed:17488717, ECO:0000269|PubMed:9367992}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- SUBUNIT: Interacts with KIF20A, which is required to localize
CC       CDC14 to the midzone of the mitotic spindle.
CC       {ECO:0000269|PubMed:15263015}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9367992}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:11901424, ECO:0000269|PubMed:12134069}.
CC       Cytoplasm, cytoskeleton, spindle pole
CC       {ECO:0000269|PubMed:11901424, ECO:0000269|PubMed:15263015}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:15263015}.
CC       Cell projection, kinocilium {ECO:0000250|UniProtKB:Q6GQT0}.
CC       Note=Centrosomal during interphase, released into the cytoplasm at
CC       the onset of mitosis. Subsequently localizes to the mitotic
CC       spindle pole and at the central spindle (PubMed:12134069,
CC       PubMed:11901424, PubMed:15263015). Present along both the
CC       transient kinocilia of developing cochlear hair cells and the
CC       persistent kinocilia of vestibular hair cells (By similarity).
CC       {ECO:0000250|UniProtKB:Q6GQT0, ECO:0000269|PubMed:11901424,
CC       ECO:0000269|PubMed:12134069, ECO:0000269|PubMed:15263015}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=CDC14A1;
CC         IsoId=Q9UNH5-1; Sequence=Displayed;
CC       Name=2; Synonyms=CDC14A2;
CC         IsoId=Q9UNH5-2; Sequence=VSP_012037;
CC       Name=3; Synonyms=CDC14A3;
CC         IsoId=Q9UNH5-3; Sequence=VSP_012035, VSP_012036;
CC       Name=4; Synonyms=CDC14A4;
CC         IsoId=Q9UNH5-4; Sequence=VSP_012322, VSP_012323;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q9UNH5-5; Sequence=VSP_047597;
CC   -!- DOMAIN: Composed of two structurally equivalent A and B domains
CC       that adopt a dual specificity protein phosphatase (DSP) fold.
CC       {ECO:0000250}.
CC   -!- DISEASE: Deafness, autosomal recessive, 105 (DFNB105)
CC       [MIM:616958]: A form of non-syndromic sensorineural hearing loss.
CC       Sensorineural deafness results from damage to the neural receptors
CC       of the inner ear, the nerve pathways to the brain, or the area of
CC       the brain that receives sound information.
CC       {ECO:0000269|PubMed:27259055}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class CDC14 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB88277.1; Type=Frameshift; Positions=6; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc14a/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000367; AAB88277.1; ALT_FRAME; mRNA.
DR   EMBL; AF122013; AAD49217.1; -; mRNA.
DR   EMBL; AF064102; AAC16659.1; -; mRNA.
DR   EMBL; AF064103; AAC16660.1; -; mRNA.
DR   EMBL; DQ530256; ABF74568.1; -; mRNA.
DR   EMBL; AY623111; AAT38107.1; -; Genomic_DNA.
DR   EMBL; AL589990; CAH70068.1; -; Genomic_DNA.
DR   EMBL; AC104457; CAH70068.1; JOINED; Genomic_DNA.
DR   EMBL; AL589990; CAH70069.1; -; Genomic_DNA.
DR   EMBL; AC104457; CAH70069.1; JOINED; Genomic_DNA.
DR   EMBL; AL589990; CAH70070.1; -; Genomic_DNA.
DR   EMBL; AC104457; CAH70070.1; JOINED; Genomic_DNA.
DR   EMBL; CH471097; EAW72956.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72958.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72959.1; -; Genomic_DNA.
DR   EMBL; BC038979; AAH38979.1; -; mRNA.
DR   EMBL; BC093916; AAH93916.1; -; mRNA.
DR   EMBL; BC093918; AAH93918.1; -; mRNA.
DR   CCDS; CCDS769.1; -. [Q9UNH5-1]
DR   CCDS; CCDS770.1; -. [Q9UNH5-2]
DR   CCDS; CCDS771.1; -. [Q9UNH5-3]
DR   RefSeq; NP_001306139.1; NM_001319210.1. [Q9UNH5-5]
DR   RefSeq; NP_001306140.1; NM_001319211.1.
DR   RefSeq; NP_001306141.1; NM_001319212.1.
DR   RefSeq; NP_003663.2; NM_003672.3. [Q9UNH5-1]
DR   RefSeq; NP_201569.1; NM_033312.2. [Q9UNH5-2]
DR   RefSeq; NP_201570.1; NM_033313.2. [Q9UNH5-3]
DR   UniGene; Hs.127411; -.
DR   ProteinModelPortal; Q9UNH5; -.
DR   SMR; Q9UNH5; -.
DR   BioGrid; 114126; 11.
DR   IntAct; Q9UNH5; 1.
DR   MINT; MINT-8330048; -.
DR   STRING; 9606.ENSP00000354916; -.
DR   BindingDB; Q9UNH5; -.
DR   ChEMBL; CHEMBL1772926; -.
DR   DEPOD; Q9UNH5; -.
DR   iPTMnet; Q9UNH5; -.
DR   PhosphoSitePlus; Q9UNH5; -.
DR   BioMuta; CDC14A; -.
DR   DMDM; 55976620; -.
DR   EPD; Q9UNH5; -.
DR   PaxDb; Q9UNH5; -.
DR   PeptideAtlas; Q9UNH5; -.
DR   PRIDE; Q9UNH5; -.
DR   Ensembl; ENST00000336454; ENSP00000336739; ENSG00000079335. [Q9UNH5-1]
DR   Ensembl; ENST00000361544; ENSP00000354916; ENSG00000079335. [Q9UNH5-2]
DR   Ensembl; ENST00000370124; ENSP00000359142; ENSG00000079335. [Q9UNH5-3]
DR   GeneID; 8556; -.
DR   KEGG; hsa:8556; -.
DR   UCSC; uc001dte.5; human. [Q9UNH5-1]
DR   CTD; 8556; -.
DR   DisGeNET; 8556; -.
DR   GeneCards; CDC14A; -.
DR   HGNC; HGNC:1718; CDC14A.
DR   HPA; HPA023783; -.
DR   MalaCards; CDC14A; -.
DR   MIM; 603504; gene.
DR   MIM; 616958; phenotype.
DR   neXtProt; NX_Q9UNH5; -.
DR   OpenTargets; ENSG00000079335; -.
DR   PharmGKB; PA26254; -.
DR   eggNOG; KOG1720; Eukaryota.
DR   eggNOG; COG2453; LUCA.
DR   GeneTree; ENSGT00390000010254; -.
DR   HOGENOM; HOG000198341; -.
DR   HOVERGEN; HBG050818; -.
DR   InParanoid; Q9UNH5; -.
DR   KO; K06639; -.
DR   OMA; LIGACEF; -.
DR   OrthoDB; EOG091G04FM; -.
DR   PhylomeDB; Q9UNH5; -.
DR   TreeFam; TF101053; -.
DR   Reactome; R-HSA-176407; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   SIGNOR; Q9UNH5; -.
DR   GeneWiki; CDC14A; -.
DR   GenomeRNAi; 8556; -.
DR   PRO; PR:Q9UNH5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000079335; -.
DR   CleanEx; HS_CDC14A; -.
DR   ExpressionAtlas; Q9UNH5; baseline and differential.
DR   Genevisible; Q9UNH5; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0060091; C:kinocilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0072686; C:mitotic spindle; IBA:GO_Central.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0000922; C:spindle pole; IBA:GO_Central.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; TAS:ProtInc.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0071850; P:mitotic cell cycle arrest; IBA:GO_Central.
DR   GO; GO:0051256; P:mitotic spindle midzone assembly; IBA:GO_Central.
DR   GO; GO:0007096; P:regulation of exit from mitosis; IBA:GO_Central.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR029260; DSPn.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR026068; Dual_Pase_CDC14A.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR23339:SF83; PTHR23339:SF83; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   Pfam; PF14671; DSPn; 1.
DR   SMART; SM00195; DSPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Cell projection;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Deafness; Hydrolase;
KW   Non-syndromic deafness; Nucleus; Phosphoprotein; Polymorphism;
KW   Protein phosphatase; Reference proteome.
FT   CHAIN         1    594       Dual specificity protein phosphatase
FT                                CDC14A.
FT                                /FTId=PRO_0000094876.
FT   REGION        7    162       A.
FT   REGION      163    176       Linker.
FT   REGION      177    343       B.
FT   ACT_SITE    278    278       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   MOD_RES     484    484       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     583    583       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     174    191       RVENGDFNWIVPGKFLAF -> VILFTPLKPTFLISKSIM
FT                                (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012322.
FT   VAR_SEQ     192    594       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012323.
FT   VAR_SEQ     380    383       DNLE -> VSFP (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_012035.
FT   VAR_SEQ     384    594       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_012036.
FT   VAR_SEQ     586    594       SLQSEYVHY -> VSAQTPPPGPQNPECNFCALPSQPRLPP
FT                                KKFNSAKEAF (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_012037.
FT   VAR_SEQ     586    594       SLQSEYVHY -> CSCLLLVFRKPFLGSPLLSLPISHL
FT                                (in isoform 5). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_047597.
FT   VARIANT     345    345       R -> Q (in dbSNP:rs28364897).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019957.
FT   VARIANT     493    493       D -> Y (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035655.
FT   VARIANT     589    589       S -> F (in dbSNP:rs28364923).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019958.
FT   MUTAGEN     251    251       D->A: Loss of phosphatase activity.
FT                                {ECO:0000269|PubMed:12134069}.
FT   MUTAGEN     278    278       C->S: Loss of phosphatase activity.
FT                                {ECO:0000269|PubMed:11598127,
FT                                ECO:0000269|PubMed:12134069}.
FT   MUTAGEN     284    284       R->A: Loss of phosphatase activity.
FT                                {ECO:0000269|PubMed:12134069}.
FT   MUTAGEN     362    362       M->A: Inappropriate nucleolar
FT                                localization; when associated with A-364.
FT                                {ECO:0000269|PubMed:11901424}.
FT   MUTAGEN     364    364       I->A: Inappropriate nucleolar
FT                                localization; when associated with A-362.
FT                                {ECO:0000269|PubMed:11901424}.
FT   CONFLICT    164    164       F -> I (in Ref. 1; AAB88277).
FT                                {ECO:0000305}.
FT   CONFLICT    182    182       W -> C (in Ref. 1; AAB88277).
FT                                {ECO:0000305}.
SQ   SEQUENCE   594 AA;  66574 MW;  D5552E2BAEEA84DF CRC64;
     MAAESGELIG ACEFMKDRLY FATLRNRPKS TVNTHYFSID EELVYENFYA DFGPLNLAMV
     YRYCCKLNKK LKSYSLSRKK IVHYTCFDQR KRANAAFLIG AYAVIYLKKT PEEAYRALLS
     GSNPPYLPFR DASFGNCTYN LTILDCLQGI RKGLQHGFFD FETFDVDEYE HYERVENGDF
     NWIVPGKFLA FSGPHPKSKI ENGYPLHAPE AYFPYFKKHN VTAVVRLNKK IYEAKRFTDA
     GFEHYDLFFI DGSTPSDNIV RRFLNICENT EGAIAVHCKA GLGRTGTLIA CYVMKHYRFT
     HAEIIAWIRI CRPGSIIGPQ QHFLEEKQAS LWVQGDIFRS KLKNRPSSEG SINKILSGLD
     DMSIGGNLSK TQNMERFGED NLEDDDVEMK NGITQGDKLR ALKSQRQPRT SPSCAFRSDD
     TKGHPRAVSQ PFRLSSSLQG SAVTLKTSKM ALSPSATAKR INRTSLSSGA TVRSFSINSR
     LASSLGNLNA ATDDPENKKT SSSSKAGFTA SPFTNLLNGS SQPTTRNYPE LNNNQYNRSS
     NSNGGNLNSP PGPHSAKTEE HTTILRPSYT GLSSSSARFL SRSIPSLQSE YVHY
//
